IN8bio, Inc.
INAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $413,383 | $1,236,411 | $1,453,082 | $2,473,490 |
| - Cash | $11,120 | $21,282 | $18,182 | $37,021 |
| + Debt | $5,030 | $4,893 | $5,874 | $2,410 |
| Enterprise Value | $407,293 | $1,220,022 | $1,440,774 | $2,438,879 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$2,501 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$26,944 | -$27,506 | -$27,418 | -$13,865 |
| % Margin | – | – | – | – |
| Net Income | -$30,437 | -$30,007 | -$28,521 | -$14,653 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.57 | -1 | -1.36 | -0.78 |
| % Growth | 43% | 26.5% | -74.4% | – |
| Operating Cash Flow | -$24,149 | -$23,340 | -$24,121 | -$13,509 |
| Capital Expenditures | -$104 | -$600 | -$3,705 | -$309 |
| Free Cash Flow | -$24,253 | -$23,940 | -$27,826 | -$13,818 |